Review





Similar Products

99
ATCC human hepatoma cell lines hepg2
SHBs is symmetrically dimethylated at arginine 169. (A–C) Huh7 and <t>HepG2</t> cells were transfected with plasmids encoding SHBs–Strep–Flag or Strep–Flag control. Strep pull–down (IP:Strep) was performed, followed by Western blot (WB) with antibodies against (A) monomethylarginine (MMA), (B) asymmetric dimethylarginine (ADMA), or (C) symmetric dimethylarginine (SDMA). SHBs in the IP fraction and SHBs/β–actin in input lysates are shown as controls. (D) Cells expressing SHBs–Strep–Flag were treated with adenosine dialdehyde (ADOX, 40 μM) for 36 h, followed by Strep pull–down and WB for SDMA and SHBs. Densitometric ratios (SDMA/IP–SHBs and SHBs/β–actin) are shown above/below the blots. (E) Huh7 cells were transfected with plasmids encoding SHBs–Strep–Flag or the indicated R→K mutants (R73K, R78K, R79K, R169K). SDMA on immunoprecipitated SHBs was assessed by Strep pull–down and WB; densitometric SDMA/IP–SHBs ratios are shown above the blots. (F–G) HepG2 cells were transfected with plasmids encoding SHBs–Strep–Flag or SHBs/R169K–Strep–Flag (F) and SHBs/R169A–Strep–Flag (G) and analyzed by Strep pull–down and WB as in (E).
Human Hepatoma Cell Lines Hepg2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human hepatoma cell lines hepg2/product/ATCC
Average 99 stars, based on 1 article reviews
human hepatoma cell lines hepg2 - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

99
ATCC hepg2 human hepatoma cells
Fucoxanthin directly targets and thermally stabilizes GRP78. (A) Schematic diagram of the drug affinity responsive target stability (DARTS) assay workflow used to identify fucoxanthin‐binding proteins. (B) Representative silver‐stained SDS‐PAGE gel of DARTS assay. <t>HepG2</t> cell lysates were incubated with fucoxanthin (Fux, 100 μM) or DMSO for 1 h, followed by proteolysis with pronase (1:100 ratio) for 20 min. The black arrow indicates a protected protein band near 78 kDa, identified as GRP78 by MS. (C) Cellular thermal shift assay (CETSA). HepG2 lysates treated with Fux (100 μM) were heated at the indicated temperature gradient (37°C–60°C). Western blots show enhanced thermal stability of GRP78 in the presence of Fux. (D) Isothermal dose–response (ITDR) CETSA. Lysates were treated with increasing concentrations of Fux (10 −3 to 10 2 μM) at a fixed temperature (52°C), confirming dose‐dependent stabilization of GRP78.
Hepg2 Human Hepatoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hepg2 human hepatoma cells/product/ATCC
Average 99 stars, based on 1 article reviews
hepg2 human hepatoma cells - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

99
ATCC human hepatoma hepg2 cells
Fucoxanthin directly targets and thermally stabilizes GRP78. (A) Schematic diagram of the drug affinity responsive target stability (DARTS) assay workflow used to identify fucoxanthin‐binding proteins. (B) Representative silver‐stained SDS‐PAGE gel of DARTS assay. <t>HepG2</t> cell lysates were incubated with fucoxanthin (Fux, 100 μM) or DMSO for 1 h, followed by proteolysis with pronase (1:100 ratio) for 20 min. The black arrow indicates a protected protein band near 78 kDa, identified as GRP78 by MS. (C) Cellular thermal shift assay (CETSA). HepG2 lysates treated with Fux (100 μM) were heated at the indicated temperature gradient (37°C–60°C). Western blots show enhanced thermal stability of GRP78 in the presence of Fux. (D) Isothermal dose–response (ITDR) CETSA. Lysates were treated with increasing concentrations of Fux (10 −3 to 10 2 μM) at a fixed temperature (52°C), confirming dose‐dependent stabilization of GRP78.
Human Hepatoma Hepg2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human hepatoma hepg2 cells/product/ATCC
Average 99 stars, based on 1 article reviews
human hepatoma hepg2 cells - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

99
ATCC human hepatoma cells hepg2
Fucoxanthin directly targets and thermally stabilizes GRP78. (A) Schematic diagram of the drug affinity responsive target stability (DARTS) assay workflow used to identify fucoxanthin‐binding proteins. (B) Representative silver‐stained SDS‐PAGE gel of DARTS assay. <t>HepG2</t> cell lysates were incubated with fucoxanthin (Fux, 100 μM) or DMSO for 1 h, followed by proteolysis with pronase (1:100 ratio) for 20 min. The black arrow indicates a protected protein band near 78 kDa, identified as GRP78 by MS. (C) Cellular thermal shift assay (CETSA). HepG2 lysates treated with Fux (100 μM) were heated at the indicated temperature gradient (37°C–60°C). Western blots show enhanced thermal stability of GRP78 in the presence of Fux. (D) Isothermal dose–response (ITDR) CETSA. Lysates were treated with increasing concentrations of Fux (10 −3 to 10 2 μM) at a fixed temperature (52°C), confirming dose‐dependent stabilization of GRP78.
Human Hepatoma Cells Hepg2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human hepatoma cells hepg2/product/ATCC
Average 99 stars, based on 1 article reviews
human hepatoma cells hepg2 - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

99
ATCC human hepatoma cell line hepg2
Fucoxanthin directly targets and thermally stabilizes GRP78. (A) Schematic diagram of the drug affinity responsive target stability (DARTS) assay workflow used to identify fucoxanthin‐binding proteins. (B) Representative silver‐stained SDS‐PAGE gel of DARTS assay. <t>HepG2</t> cell lysates were incubated with fucoxanthin (Fux, 100 μM) or DMSO for 1 h, followed by proteolysis with pronase (1:100 ratio) for 20 min. The black arrow indicates a protected protein band near 78 kDa, identified as GRP78 by MS. (C) Cellular thermal shift assay (CETSA). HepG2 lysates treated with Fux (100 μM) were heated at the indicated temperature gradient (37°C–60°C). Western blots show enhanced thermal stability of GRP78 in the presence of Fux. (D) Isothermal dose–response (ITDR) CETSA. Lysates were treated with increasing concentrations of Fux (10 −3 to 10 2 μM) at a fixed temperature (52°C), confirming dose‐dependent stabilization of GRP78.
Human Hepatoma Cell Line Hepg2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human hepatoma cell line hepg2/product/ATCC
Average 99 stars, based on 1 article reviews
human hepatoma cell line hepg2 - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

Image Search Results


SHBs is symmetrically dimethylated at arginine 169. (A–C) Huh7 and HepG2 cells were transfected with plasmids encoding SHBs–Strep–Flag or Strep–Flag control. Strep pull–down (IP:Strep) was performed, followed by Western blot (WB) with antibodies against (A) monomethylarginine (MMA), (B) asymmetric dimethylarginine (ADMA), or (C) symmetric dimethylarginine (SDMA). SHBs in the IP fraction and SHBs/β–actin in input lysates are shown as controls. (D) Cells expressing SHBs–Strep–Flag were treated with adenosine dialdehyde (ADOX, 40 μM) for 36 h, followed by Strep pull–down and WB for SDMA and SHBs. Densitometric ratios (SDMA/IP–SHBs and SHBs/β–actin) are shown above/below the blots. (E) Huh7 cells were transfected with plasmids encoding SHBs–Strep–Flag or the indicated R→K mutants (R73K, R78K, R79K, R169K). SDMA on immunoprecipitated SHBs was assessed by Strep pull–down and WB; densitometric SDMA/IP–SHBs ratios are shown above the blots. (F–G) HepG2 cells were transfected with plasmids encoding SHBs–Strep–Flag or SHBs/R169K–Strep–Flag (F) and SHBs/R169A–Strep–Flag (G) and analyzed by Strep pull–down and WB as in (E).

Journal: Tumour Virus Research

Article Title: PRMT5–mediated symmetric dimethylation of SHBs at Arg169 stabilizes SHBs and promotes angiogenesis and tumor growth

doi: 10.1016/j.tvr.2026.200340

Figure Lengend Snippet: SHBs is symmetrically dimethylated at arginine 169. (A–C) Huh7 and HepG2 cells were transfected with plasmids encoding SHBs–Strep–Flag or Strep–Flag control. Strep pull–down (IP:Strep) was performed, followed by Western blot (WB) with antibodies against (A) monomethylarginine (MMA), (B) asymmetric dimethylarginine (ADMA), or (C) symmetric dimethylarginine (SDMA). SHBs in the IP fraction and SHBs/β–actin in input lysates are shown as controls. (D) Cells expressing SHBs–Strep–Flag were treated with adenosine dialdehyde (ADOX, 40 μM) for 36 h, followed by Strep pull–down and WB for SDMA and SHBs. Densitometric ratios (SDMA/IP–SHBs and SHBs/β–actin) are shown above/below the blots. (E) Huh7 cells were transfected with plasmids encoding SHBs–Strep–Flag or the indicated R→K mutants (R73K, R78K, R79K, R169K). SDMA on immunoprecipitated SHBs was assessed by Strep pull–down and WB; densitometric SDMA/IP–SHBs ratios are shown above the blots. (F–G) HepG2 cells were transfected with plasmids encoding SHBs–Strep–Flag or SHBs/R169K–Strep–Flag (F) and SHBs/R169A–Strep–Flag (G) and analyzed by Strep pull–down and WB as in (E).

Article Snippet: Human hepatoma cell lines HepG2 (ATCC, HB–8065) and Huh7 (JCRB, JCRB0403), endothelial cell line EA.hy926 (ATCC, CRL–2922TM), and HEK293T cells (ATCC, CRL–3216) were obtained from the American Type Culture Collection (ATCC) and the Japanese Collection of Research Bioresources Cell Bank (JCRB, Japan).

Techniques: Transfection, Control, Western Blot, Expressing, Immunoprecipitation

PRMT interacts with SHBs. (A) Huh7 cells were co–transfected with plasmids encoding SHBs–Strep–Flag (or Strep–Flag control) together with Flag–PRMT9. Strep pull–down was followed by WB with anti–Flag and anti–SHBs to assess co–precipitation. (B) Huh7 and HepG2 cells were co–transfected with plasmids encoding SHBs–Strep–Flag (or Strep–Flag control) together with Flag–PRMT5 and analyzed by Strep pull–down and WB as in (A). (C) Huh7 and HepG2 cells were co–transfected with plasmids encoding Strep–Flag–PRMT5 and SHBs–myc. Strep pull–down was performed and precipitates were immunoblotted for SHBs and Flag to validate the interaction. (D) Direct interaction between SHBs and PRMT5 was tested by GST pull–down. Purified GST or GST–PRMT5 (Coomassie–stained gel, left) was incubated with in vitro–translated SHBs–Flag, and bound SHBs was detected by WB using anti–Flag (right). (E) Confocal microscopy showing subcellular localization of SHBs (red) and PRMT5 (green) with nuclear DAPI staining (blue). Merged images and a representative line–scan fluorescence intensity profile (right) are shown.

Journal: Tumour Virus Research

Article Title: PRMT5–mediated symmetric dimethylation of SHBs at Arg169 stabilizes SHBs and promotes angiogenesis and tumor growth

doi: 10.1016/j.tvr.2026.200340

Figure Lengend Snippet: PRMT interacts with SHBs. (A) Huh7 cells were co–transfected with plasmids encoding SHBs–Strep–Flag (or Strep–Flag control) together with Flag–PRMT9. Strep pull–down was followed by WB with anti–Flag and anti–SHBs to assess co–precipitation. (B) Huh7 and HepG2 cells were co–transfected with plasmids encoding SHBs–Strep–Flag (or Strep–Flag control) together with Flag–PRMT5 and analyzed by Strep pull–down and WB as in (A). (C) Huh7 and HepG2 cells were co–transfected with plasmids encoding Strep–Flag–PRMT5 and SHBs–myc. Strep pull–down was performed and precipitates were immunoblotted for SHBs and Flag to validate the interaction. (D) Direct interaction between SHBs and PRMT5 was tested by GST pull–down. Purified GST or GST–PRMT5 (Coomassie–stained gel, left) was incubated with in vitro–translated SHBs–Flag, and bound SHBs was detected by WB using anti–Flag (right). (E) Confocal microscopy showing subcellular localization of SHBs (red) and PRMT5 (green) with nuclear DAPI staining (blue). Merged images and a representative line–scan fluorescence intensity profile (right) are shown.

Article Snippet: Human hepatoma cell lines HepG2 (ATCC, HB–8065) and Huh7 (JCRB, JCRB0403), endothelial cell line EA.hy926 (ATCC, CRL–2922TM), and HEK293T cells (ATCC, CRL–3216) were obtained from the American Type Culture Collection (ATCC) and the Japanese Collection of Research Bioresources Cell Bank (JCRB, Japan).

Techniques: Transfection, Control, Purification, Staining, Incubation, In Vitro, Confocal Microscopy, Fluorescence

PRMT5 stabilizes SHBs protein expression in an Arg169–dependent manner. (A) Huh7 and HepG2 cells were co–transfected with plasmids encoding SHBs–Strep–Flag or SHBs/R169K–Strep–Flag together with increasing amounts of Flag–PRMT5 (0, 1, 3 μg). Whole–cell lysates were immunoblotted for SHBs, Flag, and β–actin; SHBs/β–actin ratios are shown above the blots. (B) Cells expressing SHBs–Strep–Flag or SHBs/R169K–Strep–Flag were transfected with NC or PRMT5 siRNAs (#1, #2). Lysates were immunoblotted for SHBs, PRMT5, and β–actin; SHBs/β–actin ratios are shown. (C–D) Cycloheximide (CHX) chase assays in (C) Huh7 and (D) HepG2 cells. Cells expressing SHBs or SHBs/R169K with vector or Flag–PRMT5 were treated with CHX for the indicated times (0–120 min), followed by WB for SHBs, Flag, and β–actin. Plots show relative SHBs levels normalized to time 0 with fitted linear regression (equations displayed). (E) HepG2 cells were co–transfected with plasmids encoding SHBs–Strep, HA–K48Ub, together with or without Flag–PRMT5, and treated with MG132 (20 μM) for 8 h, the ubiquitination levels of SHBs was evaluated via ubiquitination assay analysis. (F) HepG2 cells were co–transfected with plasmid encoding SHBs–Strep and TRIM21–myc (or control vector) and Flag–PRMT5 (or control vector), the cell lysates were subjected to immunoprecipitation using Strep–Tactin and analyzed by immunoblotting.

Journal: Tumour Virus Research

Article Title: PRMT5–mediated symmetric dimethylation of SHBs at Arg169 stabilizes SHBs and promotes angiogenesis and tumor growth

doi: 10.1016/j.tvr.2026.200340

Figure Lengend Snippet: PRMT5 stabilizes SHBs protein expression in an Arg169–dependent manner. (A) Huh7 and HepG2 cells were co–transfected with plasmids encoding SHBs–Strep–Flag or SHBs/R169K–Strep–Flag together with increasing amounts of Flag–PRMT5 (0, 1, 3 μg). Whole–cell lysates were immunoblotted for SHBs, Flag, and β–actin; SHBs/β–actin ratios are shown above the blots. (B) Cells expressing SHBs–Strep–Flag or SHBs/R169K–Strep–Flag were transfected with NC or PRMT5 siRNAs (#1, #2). Lysates were immunoblotted for SHBs, PRMT5, and β–actin; SHBs/β–actin ratios are shown. (C–D) Cycloheximide (CHX) chase assays in (C) Huh7 and (D) HepG2 cells. Cells expressing SHBs or SHBs/R169K with vector or Flag–PRMT5 were treated with CHX for the indicated times (0–120 min), followed by WB for SHBs, Flag, and β–actin. Plots show relative SHBs levels normalized to time 0 with fitted linear regression (equations displayed). (E) HepG2 cells were co–transfected with plasmids encoding SHBs–Strep, HA–K48Ub, together with or without Flag–PRMT5, and treated with MG132 (20 μM) for 8 h, the ubiquitination levels of SHBs was evaluated via ubiquitination assay analysis. (F) HepG2 cells were co–transfected with plasmid encoding SHBs–Strep and TRIM21–myc (or control vector) and Flag–PRMT5 (or control vector), the cell lysates were subjected to immunoprecipitation using Strep–Tactin and analyzed by immunoblotting.

Article Snippet: Human hepatoma cell lines HepG2 (ATCC, HB–8065) and Huh7 (JCRB, JCRB0403), endothelial cell line EA.hy926 (ATCC, CRL–2922TM), and HEK293T cells (ATCC, CRL–3216) were obtained from the American Type Culture Collection (ATCC) and the Japanese Collection of Research Bioresources Cell Bank (JCRB, Japan).

Techniques: Expressing, Transfection, Plasmid Preparation, Ubiquitin Proteomics, Control, Immunoprecipitation, Western Blot

Arg169 symmetric dimethylation is required for SHBs–driven angiogenesis and tumor growth. (A) WB analysis of SHBs and BIP expression in stably transduced Huh7 and HepG2 cells (Vector, SHBs, and SHBs/R169K). (B) ELISA measurement of VEGFA levels in the supernatants of Huh7/HepG2–Vector, Huh7/HepG2–SHBs, or Huh7/HepG2–SHBs/R169K cells. (C) Endothelial tube formation assay. EA.hy926 cells were cultured with conditioned media (CM) from Huh7 or HepG2 stable lines (Vector, SHBs, SHBs/R169K). Representative images and quantification of mesh numbers are shown. (D) Transwell migration assay. EA.hy926 cells were assessed for migration in response to CM from the indicated stable lines. Representative images and quantification of migrated cell numbers per field are shown. (E) Representative images of excised subcutaneous xenograft tumors derived from Huh7–Vector, Huh7–SHBs, or Huh7–SHBs/R169K cells. (F) Tumor growth curves (tumor volume over time) for the indicated xenograft groups. (G) Tumor weights at endpoint. (H) Representative immunohistochemical staining of xenograft tumors for CD31 and SHBs, with quantification of microvessel density (MVD) based on CD31 staining. Data are presented as mean ± SD; ∗ P < 0.05 as indicated.

Journal: Tumour Virus Research

Article Title: PRMT5–mediated symmetric dimethylation of SHBs at Arg169 stabilizes SHBs and promotes angiogenesis and tumor growth

doi: 10.1016/j.tvr.2026.200340

Figure Lengend Snippet: Arg169 symmetric dimethylation is required for SHBs–driven angiogenesis and tumor growth. (A) WB analysis of SHBs and BIP expression in stably transduced Huh7 and HepG2 cells (Vector, SHBs, and SHBs/R169K). (B) ELISA measurement of VEGFA levels in the supernatants of Huh7/HepG2–Vector, Huh7/HepG2–SHBs, or Huh7/HepG2–SHBs/R169K cells. (C) Endothelial tube formation assay. EA.hy926 cells were cultured with conditioned media (CM) from Huh7 or HepG2 stable lines (Vector, SHBs, SHBs/R169K). Representative images and quantification of mesh numbers are shown. (D) Transwell migration assay. EA.hy926 cells were assessed for migration in response to CM from the indicated stable lines. Representative images and quantification of migrated cell numbers per field are shown. (E) Representative images of excised subcutaneous xenograft tumors derived from Huh7–Vector, Huh7–SHBs, or Huh7–SHBs/R169K cells. (F) Tumor growth curves (tumor volume over time) for the indicated xenograft groups. (G) Tumor weights at endpoint. (H) Representative immunohistochemical staining of xenograft tumors for CD31 and SHBs, with quantification of microvessel density (MVD) based on CD31 staining. Data are presented as mean ± SD; ∗ P < 0.05 as indicated.

Article Snippet: Human hepatoma cell lines HepG2 (ATCC, HB–8065) and Huh7 (JCRB, JCRB0403), endothelial cell line EA.hy926 (ATCC, CRL–2922TM), and HEK293T cells (ATCC, CRL–3216) were obtained from the American Type Culture Collection (ATCC) and the Japanese Collection of Research Bioresources Cell Bank (JCRB, Japan).

Techniques: Expressing, Stable Transfection, Plasmid Preparation, Enzyme-linked Immunosorbent Assay, Endothelial Tube Formation Assay, Cell Culture, Transwell Migration Assay, Migration, Derivative Assay, Immunohistochemical staining, Staining

Fucoxanthin directly targets and thermally stabilizes GRP78. (A) Schematic diagram of the drug affinity responsive target stability (DARTS) assay workflow used to identify fucoxanthin‐binding proteins. (B) Representative silver‐stained SDS‐PAGE gel of DARTS assay. HepG2 cell lysates were incubated with fucoxanthin (Fux, 100 μM) or DMSO for 1 h, followed by proteolysis with pronase (1:100 ratio) for 20 min. The black arrow indicates a protected protein band near 78 kDa, identified as GRP78 by MS. (C) Cellular thermal shift assay (CETSA). HepG2 lysates treated with Fux (100 μM) were heated at the indicated temperature gradient (37°C–60°C). Western blots show enhanced thermal stability of GRP78 in the presence of Fux. (D) Isothermal dose–response (ITDR) CETSA. Lysates were treated with increasing concentrations of Fux (10 −3 to 10 2 μM) at a fixed temperature (52°C), confirming dose‐dependent stabilization of GRP78.

Journal: Food Science & Nutrition

Article Title: Fucoxanthin Ameliorates MASLD by Directly Targeting GRP78 to Restore ER Homeostasis and Activate AMPK Signaling

doi: 10.1002/fsn3.71813

Figure Lengend Snippet: Fucoxanthin directly targets and thermally stabilizes GRP78. (A) Schematic diagram of the drug affinity responsive target stability (DARTS) assay workflow used to identify fucoxanthin‐binding proteins. (B) Representative silver‐stained SDS‐PAGE gel of DARTS assay. HepG2 cell lysates were incubated with fucoxanthin (Fux, 100 μM) or DMSO for 1 h, followed by proteolysis with pronase (1:100 ratio) for 20 min. The black arrow indicates a protected protein band near 78 kDa, identified as GRP78 by MS. (C) Cellular thermal shift assay (CETSA). HepG2 lysates treated with Fux (100 μM) were heated at the indicated temperature gradient (37°C–60°C). Western blots show enhanced thermal stability of GRP78 in the presence of Fux. (D) Isothermal dose–response (ITDR) CETSA. Lysates were treated with increasing concentrations of Fux (10 −3 to 10 2 μM) at a fixed temperature (52°C), confirming dose‐dependent stabilization of GRP78.

Article Snippet: HepG2 human hepatoma cells were obtained from the American Type Culture Collection (ATCC, #HB‐8065) and cultured in DMEM supplemented with 10% (v/v) FBS and 1% penicillin/streptomycin in a humidified atmosphere containing 5% CO 2 at 37°C.

Techniques: Binding Assay, Staining, SDS Page, Incubation, Thermal Shift Assay, Western Blot

Fucoxanthin mitigates palmitic acid (PA)‐induced ER stress in HepG2 cells. (A, B) Representative western blots and quantification of GRP78 (A) and p‐eIF2α/eIF2α ratio (B) in HepG2 cells treated with PA (100 μM) ± fucoxanthin (Fux) for 24 h. (C–F) Relative mRNA levels of ER stress‐related genes: HSPA5 (C), ATF6 (D), DDIT3 (E), and ERN1 (F). (G, H) Effect of Fux on thapsigargin (Tg)‐induced ER stress. Cells were treated with Tg (1 μM) ± Fux. (G) Western blots of GRP78 protein expression. (H) Intracellular triglyceride (TG) content normalized to total protein. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Food Science & Nutrition

Article Title: Fucoxanthin Ameliorates MASLD by Directly Targeting GRP78 to Restore ER Homeostasis and Activate AMPK Signaling

doi: 10.1002/fsn3.71813

Figure Lengend Snippet: Fucoxanthin mitigates palmitic acid (PA)‐induced ER stress in HepG2 cells. (A, B) Representative western blots and quantification of GRP78 (A) and p‐eIF2α/eIF2α ratio (B) in HepG2 cells treated with PA (100 μM) ± fucoxanthin (Fux) for 24 h. (C–F) Relative mRNA levels of ER stress‐related genes: HSPA5 (C), ATF6 (D), DDIT3 (E), and ERN1 (F). (G, H) Effect of Fux on thapsigargin (Tg)‐induced ER stress. Cells were treated with Tg (1 μM) ± Fux. (G) Western blots of GRP78 protein expression. (H) Intracellular triglyceride (TG) content normalized to total protein. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: HepG2 human hepatoma cells were obtained from the American Type Culture Collection (ATCC, #HB‐8065) and cultured in DMEM supplemented with 10% (v/v) FBS and 1% penicillin/streptomycin in a humidified atmosphere containing 5% CO 2 at 37°C.

Techniques: Western Blot, Expressing

GRP78 knockdown abolishes the lipid‐lowering effect of fucoxanthin. (A) Validation of GRP78 knockdown efficiency by western blot in HepG2 cells. GRP78 protein levels were reduced by approximately 66% in siGRP78‐transfected cells compared to siCtl group. Tubulin served as loading control. (B) Representative Oil Red O staining images (left) and quantification of lipid droplet area (right). GRP78 knockdown reversed the protective effect of Fux against PA‐induced lipid accumulation. (C) Quantification of intracellular TG levels. (D–G) Relative mRNA expression of lipid metabolism genes: Fatty acid oxidation genes PPARα (D) and CPT1 (E); lipogenic genes SREBP1C (F) and FASN (G). Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001, ns, not significant. Scale bar = 25 μm.

Journal: Food Science & Nutrition

Article Title: Fucoxanthin Ameliorates MASLD by Directly Targeting GRP78 to Restore ER Homeostasis and Activate AMPK Signaling

doi: 10.1002/fsn3.71813

Figure Lengend Snippet: GRP78 knockdown abolishes the lipid‐lowering effect of fucoxanthin. (A) Validation of GRP78 knockdown efficiency by western blot in HepG2 cells. GRP78 protein levels were reduced by approximately 66% in siGRP78‐transfected cells compared to siCtl group. Tubulin served as loading control. (B) Representative Oil Red O staining images (left) and quantification of lipid droplet area (right). GRP78 knockdown reversed the protective effect of Fux against PA‐induced lipid accumulation. (C) Quantification of intracellular TG levels. (D–G) Relative mRNA expression of lipid metabolism genes: Fatty acid oxidation genes PPARα (D) and CPT1 (E); lipogenic genes SREBP1C (F) and FASN (G). Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001, ns, not significant. Scale bar = 25 μm.

Article Snippet: HepG2 human hepatoma cells were obtained from the American Type Culture Collection (ATCC, #HB‐8065) and cultured in DMEM supplemented with 10% (v/v) FBS and 1% penicillin/streptomycin in a humidified atmosphere containing 5% CO 2 at 37°C.

Techniques: Knockdown, Biomarker Discovery, Western Blot, Transfection, Control, Staining, Expressing